Free Trial
NASDAQ:VRPX

Virpax Pharmaceuticals (VRPX) Stock Price, News & Analysis

Virpax Pharmaceuticals logo
$0.01 0.00 (0.00%)
As of 08/1/2025

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Key Stats

Today's Range
$0.0110
$0.0110
50-Day Range
$0.01
$0.46
52-Week Range
$0.01
$33.00
Volume
72 shs
Average Volume
183,074 shs
Market Capitalization
$13.66 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive VRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VRPX Stock News Headlines

Virpax Pharmaceuticals Inc trading halted, news pending
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.
Virpax receives positive Probudur results for dose range study
Virpax Pharmaceuticals announces 1-for-25 reverse stock split
See More Headlines

VRPX Stock Analysis - Frequently Asked Questions

Virpax Pharmaceuticals' stock was trading at $9.4975 at the start of the year. Since then, VRPX shares have decreased by 99.9% and is now trading at $0.0110.

Virpax Pharmaceuticals's stock reverse split on Friday, March 1st 2024.The 1-10 reverse split was announced on Friday, March 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Virpax Pharmaceuticals (VRPX) raised $15 million in an initial public offering on Wednesday, February 17th 2021. The company issued 1,400,000 shares at a price of $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virpax Pharmaceuticals investors own include AMC Entertainment (AMC), Dare Bioscience (DARE), Rallybio (RLYB), Plug Power (PLUG), SNDL (SNDL) and SOS (SOS).

Company Calendar

Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRPX
CIK
1708331
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-1,554.34%
Return on Assets
-338.29%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
0.01

Miscellaneous

Outstanding Shares
1,242,000
Free Float
4,707,000
Market Cap
$13.66 thousand
Optionable
Not Optionable
Beta
1.58
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:VRPX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners